These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1129 related items for PubMed ID: 18675085

  • 21. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 22. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 23. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation.
    Brandão A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G.
    Clin Transplant; 2008 Oct; 22(5):651-6. PubMed ID: 18549449
    [Abstract] [Full Text] [Related]

  • 24. Prognosis after liver transplantation predicted by preoperative MELD score.
    Kim DJ, Lee SK, Jo JW, Kim SJ, Kwon CH, Park JW, Han YS, Park JB.
    Transplant Proc; 2006 Sep; 38(7):2095-6. PubMed ID: 16980010
    [Abstract] [Full Text] [Related]

  • 25. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 26. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment.
    Ravaioli M, Masetti M, Ridolfi L, Capelli M, Grazi GL, Venturoli N, Di Benedetto F, Bianchi FB, Cavrini G, Faenza S, Begliomini B, Pinna AD, Gerunda GE, Ballardini G.
    Transplantation; 2007 Apr 15; 83(7):919-24. PubMed ID: 17460563
    [Abstract] [Full Text] [Related]

  • 27. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.
    Novelli G, Rossi M, Pugliese F, Poli I, Ruberto E, Martelli S, Nudo F, Morabito V, Mennini G, Berloco PB.
    Transplant Proc; 2007 Apr 15; 39(6):1864-7. PubMed ID: 17692635
    [Abstract] [Full Text] [Related]

  • 28. [The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
    Jeong EM, Hwang SG, Park HH, Park JH, Kim HT, Oh SW, Kho KH, Hong SP, Park PW, Rim GS, Kim SH.
    Taehan Kan Hakhoe Chi; 2003 Jun 15; 9(2):98-106. PubMed ID: 12824749
    [Abstract] [Full Text] [Related]

  • 29. Algorithm for prioritization of patients on the waiting list for liver transplantation.
    Gambato M, Senzolo M, Canova D, Germani G, Tomat S, Masier A, Russo FP, Perissinotto E, Zanus G, Cillo U, Burra P.
    Transplant Proc; 2007 Jun 15; 39(6):1855-6. PubMed ID: 17692632
    [Abstract] [Full Text] [Related]

  • 30. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.
    Vnitr Lek; 2006 Sep 15; 52(9):771-6. PubMed ID: 17091599
    [Abstract] [Full Text] [Related]

  • 31. Risk factors for liver transplantation waiting list mortality.
    Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    J Gastroenterol Hepatol; 2007 Jan 15; 22(1):119-24. PubMed ID: 17201891
    [Abstract] [Full Text] [Related]

  • 32. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M, Masetti M, Dazzi A, Romano A, Spaggiari M, Grazi GL, Ercolani G, Cescon M, Di Gioia P, De Ruvo N, Montalti R, Ballarin R, Di Benedetto F, Ridolfi L, Alvaro N, Ramacciato G, Morelli C, Gerunda E, Pinna AD.
    Transplant Proc; 2008 Jan 15; 40(6):1814-5. PubMed ID: 18675057
    [Abstract] [Full Text] [Related]

  • 33. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan 15; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 34. Is MELD really the definitive score for liver allocation?
    Lladó L, Figueras J, Memba R, Xiol X, Baliellas C, Vázquez S, Ramos E, Torras J, Rafecas A, Fabregat J, Lama C, Jaurrieta E.
    Liver Transpl; 2002 Sep 15; 8(9):795-8. PubMed ID: 12200780
    [Abstract] [Full Text] [Related]

  • 35. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
    Buenadicha AL, Martín LG, Martín EE, Pajares Ad, Pérez AM, Seral CC, Marugán RB.
    Transplant Proc; 2005 Nov 15; 37(9):3881-3. PubMed ID: 16386571
    [Abstract] [Full Text] [Related]

  • 36. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients.
    Brown RS, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, Lobritto S, Emond JC.
    Liver Transpl; 2002 Mar 15; 8(3):278-84. PubMed ID: 11910574
    [Abstract] [Full Text] [Related]

  • 37. Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 year.
    Lee YM, Wai CT, Da Costa M, Lee KH, Sutedja D, Tan KC, Isaac J, Lim SG.
    Transplant Proc; 2005 Dec 15; 37(10):4365-6. PubMed ID: 16387121
    [Abstract] [Full Text] [Related]

  • 38. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB, Fundakowski CE, Lisker-Melman M, Crippin JS, Pilgram TK, Chapman W, Darcy MD.
    J Vasc Interv Radiol; 2004 Nov 15; 15(11):1209-18. PubMed ID: 15525739
    [Abstract] [Full Text] [Related]

  • 39. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Huang YH, Lee PC, Chang FY, Lee SD.
    Liver Transpl; 2004 Dec 15; 10(12):1507-13. PubMed ID: 15558587
    [Abstract] [Full Text] [Related]

  • 40. Deaths on the liver transplant waiting list: an analysis of competing risks.
    Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER.
    Hepatology; 2006 Feb 15; 43(2):345-51. PubMed ID: 16440361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.